April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Novel mutations and change of nomenclature for pathogenic variants in the TIMP3 gene causing Sorsby fundus dystrophy
Author Affiliations & Notes
  • Benjamin Bakall
    Associated Retina Consultants, Phoenix, AZ
    Ophthalmology, University of Arizona, College of Medicine Phoenix, Phoenix, AZ
  • Elliott H Sohn
    Dept of Ophthalmology, Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
  • Janet Riley
    Dept of Ophthalmology, Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
  • Dianna Brack
    Dept of Ophthalmology, Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
  • Edwin M Stone
    Dept of Ophthalmology, Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
  • Footnotes
    Commercial Relationships Benjamin Bakall, None; Elliott Sohn, None; Janet Riley, None; Dianna Brack, None; Edwin Stone, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3290. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Benjamin Bakall, Elliott H Sohn, Janet Riley, Dianna Brack, Edwin M Stone; Novel mutations and change of nomenclature for pathogenic variants in the TIMP3 gene causing Sorsby fundus dystrophy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3290.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Sorsby Fundus Dystrophy (SFD) is an autosomal dominant macular dystrophy caused by mutations in the TIMP3 gene on 22q12.3. The purpose of the study was to identify variants in the TIMP3 gene in patients SFD and to modify the nomenclature to conform to the Human Genome Variation Society (HGVS) guidelines.

Methods: Ophthalmic exam and available standard imaging techniques, including fundus photography, fluorescein angiography and ocular coherence tomography were applied to six individuals from five families. After informed consent, peripheral venous blood was obtained for DNA extraction. Sanger sequencing was initially performed for exon 5 and flanking intronic regions of the TIMP3 gene. If negative, the first four exons were analyzed for variants. Identified pathogenic variants were numbered with the start codon as +1.

Results: By exam, six individuals from five families were diagnosed with SFD including signs of early onset choroidal neovascularization. Molecular analysis revealed three novel variants in the TIMP3 protein: Cys24Arg, Tyr151Cys and Trp198Cys; and two previously published variants: Ser38Cys and Tyr191Cys.

Conclusions: The three novel mutations broaden the spectrum of the known pathogenic variants in the TIMP3 protein. All the identified variants caused formation or loss of a cysteine residue, consistent with the theory that pathogenic variants create an unpaired disulfide bond resulting in dimerization of the TIMP3 protein. In addition, we propose that all pathogenic variants are numbered from the translation initiation site according to HGVS guidelines.

Keywords: 537 gene screening • 696 retinal degenerations: hereditary • 604 mutations  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×